Related Experiment Video

Updated: May 1, 2026

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay
08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

8.6K

[Diagnosis and treatment of familial hypercholesterolemia in Spain: consensus document]

Pedro Mata1, Rodrigo Alonso2, Antonio Ruiz3

  • 1Medicina Interna, Presidente de la Fundación Hipercolesterolemia Familiar, Madrid, España.

Atencion Primaria
|April 8, 2014
PubMed

Insights

Familial hypercholesterolemia (FH) is a genetic disorder causing high LDL-cholesterol and early heart disease. Early detection via cascade screening and treatment, including statins, significantly reduces cardiovascular risk.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Metabolic Disorders

Background:

  • Familial hypercholesterolemia (FH) is a prevalent genetic disorder characterized by elevated plasma LDL-cholesterol (LDL-c) levels from birth.
  • It leads to xanthomas and premature coronary heart disease, significantly increasing morbidity and mortality.
  • Despite effective treatments, FH remains under-diagnosed and under-treated globally.

Framework:

  • Early detection through identification of index cases and cascade screening using LDL-c levels and genetic testing is crucial.
  • Established LDL-c treatment targets vary by age and risk factors: <130 mg/dL for children/young adults, <100 mg/dL for adults, and <70 mg/dL for high-risk adults.
  • Long-term statin therapy effectively reduces vascular risk, but many patients require combination therapy (e.g., with ezetimibe) or apheresis for severe cases.

Implementation:

  • This consensus paper provides recommendations for diagnosing, screening, and treating FH in both children and adults.
  • It offers specific guidance for specialists and general practitioners to enhance patient management.
  • The objective is to improve clinical outcomes and reduce the substantial burden of coronary heart disease associated with FH.

Implications:

  • Improved diagnosis and management of FH can significantly decrease coronary heart disease rates.
  • Effective treatment strategies, including pharmacotherapy and apheresis, can normalize vascular risk in FH patients.
  • Widespread implementation of screening and treatment protocols is essential for public health, reducing the long-term impact of this genetic disorder.

Keywords:
Cardiovascular diseaseCascade screeningChildren-adolescentsCribado en cascadaDiagnóstico genéticoEnfermedad cardiovascularFamilial hypercholesterolemiaGenetic testingHipercolesterolemia familiarHipercolesterolemia familiar homocigotaHomozygous familial hypercholesterolemiaNiños-adolescentesTratamientoTreatment

More Related Videos

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

7.5K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886